Trial Profile
A randomised, double-blind, parallel-group, placebo-controlled study to evaluate the changes in inflammatory markers in induced sputum following treatment with tiotropium inhalation capsules 18mcg once daily in patients with chronic obstructive pulmonary disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacodynamics; Therapeutic Use
- 17 Feb 2007 New trial record.